823 related articles for article (PubMed ID: 8579962)
21. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.
Iwaniec UT; Magee KA; Mitova-Caneva NG; Wronski TJ
Bone; 2003 Sep; 33(3):380-6. PubMed ID: 13678780
[TBL] [Abstract][Full Text] [Related]
22. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
Shen Y; Li M; Wronski TJ
Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
[TBL] [Abstract][Full Text] [Related]
24. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
25. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
26. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats.
Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):79-87. PubMed ID: 15544933
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
28. Alfacalcidol restores cancellous bone in ovariectomized rats.
Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
[TBL] [Abstract][Full Text] [Related]
29. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
30. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
32. Effects of progestins on the metabolism of cancellous bone in aged oophorectomized rats.
Yamamoto Y; Kurabayashi T; Tojo Y; Yahata T; Honda A; Tomita M; Tanaka K
Bone; 1998 May; 22(5):533-7. PubMed ID: 9600788
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
[TBL] [Abstract][Full Text] [Related]
34. Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Palkowitz A; Jee WS; Turner CH; Sato M
J Bone Miner Res; 2002 Dec; 17(12):2256-64. PubMed ID: 12469920
[TBL] [Abstract][Full Text] [Related]
35. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
Sato M; Zeng GQ; Rowley E; Turner CH
Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
[TBL] [Abstract][Full Text] [Related]
36. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
37. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models.
Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD
Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995
[TBL] [Abstract][Full Text] [Related]
38. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
39. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
[TBL] [Abstract][Full Text] [Related]
40. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
